Shi, L, Winchester, LM, Westwood, S, Baird, AL, Anand, SN, Buckley, NJ, Hye, A, Ashton, NJ, Bos, I, Vos, SJB, ten Kate, M, Scheltens, P, Teunissen, CE, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, EE, Sleegers, K, Frisoni, GB, Blin, O, Richardson, JC, Bordet, R, Molinuevo, JL, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Freund-Levi, Y, Frolich, L, Dobricic, V, Legido-Quigley, C, Barkhof, F, Andreasson, U, Blennow, K, Zetterberg, H, Streffer, J, Lill, CM, Bertram, L, Visser, PJ, Kolb, HC, Narayan, VA, Lovestone, S, Nevado-Holgado, AJ. Replication study of plasma proteins relating to Alzheimer's pathology. ALZHEIMERS & DEMENTIA. 2021; 17(9)DOI:10.1002/alz.12322. PMID:33792144. IF:16.655(Q1/1D).

Ulugut, H, Bertoux, M, Younes, K, Montembeault, M, Fumagalli, GG, Samanci, B, Illan-Gala, I, Kuchcinski, G, Leroy, M, Thompson, JC, Kobylecki, C, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R Jr, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Hansson, O, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Miller, BL, Scheltens, P, Ossenkoppele, R, van der Flier, WM, Barkhof, F, Fox, NC, Sturm, VE, Miyagawa, T, Whitwell, JL, Boeve, B, Rohrer, JD, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study. ALZHEIMERS & DEMENTIA. 2024; 20(8)DOI:10.1002/alz.14076. PMID:38982845. IF:11.100(Q1/1D).

Franzen, S, Nuytemans, K, Bourdage, R, Caramelli, P, Ellajosyula, R, Finger, E, Illan-Gala, I, Loi, SM, Morhardt, D, Pijnenburg, Y, Rascovsky, K, Williams, MM, Yokoyama, JS, Alladi, S, Ayhan, Y, Broce, I, Castro-Suarez, S, Coleman, K, de Souza, LC, Dacks, PA, de Boer, SCM, de Leon, J, Dodge, S, Grasso, S, Gupta, V, Gupta, V, Ghoshal, N, Kamath, V, Kumfor, F, Matias-Guiu, JA, Narme, P, Nielsen, TR, Okhuevbie, D, Pina-Escudero, SD, Garcia, RR, Scarioni, M, Slachevsky, A, Suarez-Gonzalez, A, Tee, BL, Tsoy, E, Ulugut, H, Babulal, GM, Onyike, CU. zZ Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research. ALZHEIMERS & DEMENTIA. 2023; 19(12)DOI:10.1002/alz.13129. PMID:37270665. IF:13.100(Q1/1D).

Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090874. PMID:39335047. IF:4.600(Q1/2D).

Grunden, N, Calabria, M, García-Sánchez, C, Pons, C, Arroyo, JA, Gómez-Ansón, B, Estévez-Garcia, MD, Belvís, R, Morollón, N, Cordero-Carcedo, M, Mur, I, Pomar, V, Domingo, P. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints. PLoS One. 2024; 19(8)DOI:10.1371/journal.pone.0302415. PMID:39116061. IF:2.600(Q2/4D).

Lora-Tamayo, J, Mancheño-Losa, M, Meléndez-Carmona, MA, Hernández-Jiménez, P, Benito, N, Murillo, O. Appropriate Duration of Antimicrobial Treatment for Prosthetic Joint Infections: A Narrative Review. Antibiotics-Basel. 2024; 13(4)DOI:10.3390/antibiotics13040293. PMID:38666969. IF:4.600(Q1/2D).

Calvo-Río, V, Secada-Gómez, C, Gutiérrez, AM, Retuerto-Guerrero, M, Font, J, Casafont-Solé, I, Mayo-Juanatey, A, Sancho, JJA, Freites, D, Hormigos, C, Puñal, NG, Arribas, GG, Sanchez, JRM, García-Valle, A, Ibañez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cortes-Hernandez, J, Sanchez, DP, Lojo, L, Pérez, ECC, Collado, P, Larios, CA, Icardo, LS, Labrador-Sánchez, E, Peralta-Ginés, C, Onaindia, IU, Plaza-Aulestia, N, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrián-Méndez, L, Pages, FAA, Riazuelo, JRL, Canales, MDF, Hernández, MJA, Bufort, MG, Pàmies, A, de Ardanaz, LS, Aguirre-del-Pino, R, Lefler, JAC, Seijas-Lopez, A, Cubero, MDC, Cofiño, ALC, Ortiz-Santamaria, V, Piñeiro, ML, Calvo, CO, Lopez, CA, Urruticoechea-Arana, A, Magallon, BG, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy-García, AM, Vilamajo, IR, Martos, AG, Lopez, BPM, Urmeneta, GS, Martín, CC, Riera, E, Bejerano, C, Castañeda, S, Blanco, R. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. RMD Open. 2026; 12(1)DOI:10.1136/rmdopen-2025-006549. PMID:41856562. IF:4.700(Q1/1D).

Agmon-Levin, N, Ignatenko, S, Gordienko, A, Cortés-Hernández, J, Narongroeknawin, P, Romanowska-Próchnicka, K, Shen, N, Ciferska, H, Kodera, M, Cheng-Chung, WJ, Leszczynski, P, Lan, JL, Mysler, E, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Lie, D, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, López, BPM, Ghanshani, SA, Lau, C, Avrameas, A, Sips, C, Oliver, SJ. B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(3)DOI:10.1016/j.ard.2025.11.015. PMID:41353079. IF:20.600(Q1/1D).

Petelytska, L, Tofani, L, Velauthapillai, A, Dobrota, R, Becker, MO, Mihai, C, Muraru, S, Elhai, M, Jordan, S, Hachulla, E, Müller-Ladner, U, Siegert, E, Allanore, Y, Riemekasten, G, Bergmann, C, Becvar, R, Solanki, K, Anic, B, Szabo, I, Stamenkovic, B, Distler, J, Carreira, PE, Cuomo, G, Castellví, I, Balbir-Gurman, A, Airo, P, Litinsky, I, Saketkoo, LA, Bertaccini, B, Vonk, M, de Vries-Bouwstra, J, Hoffmann-Vold, AM, Matucci-Cerinic, M, Distler, O, Bruni, C. The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133). ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(4)DOI:10.1016/j.ard.2025.12.008. PMID:41549016. IF:20.600(Q1/1D).

Loricera, J, Molina-Collada, J, Nieto, JC, Sánchez-Lucas, M, Silva-Díaz, MT, Moya, P, Labrador, E, Ferraz-Amaro, I, Blanco, R. Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients. DRUGS & AGING. 2026; 43(3)DOI:10.1007/s40266-026-01281-1. PMID:41714460. IF:3.800(Q2/3D).

Corominas, H, Guigini, MA, Ameruso, YS, Reina, D. Rheumatologists' perceptions of biosimilar use in Spain: the CUSTODIAN study. CURRENT MEDICAL RESEARCH AND OPINION. 2026; 42(2)DOI:10.1080/03007995.2026.2656544. PMID:42030169. IF:2.200(Q2/3D).

Valencia, AN, Retes, LS, Bartolomé-Zavala, B, Gutiérrez, GP, Bigorra, T. Allergy to Theobroma Cacao. Clinical Case Reports. 2024; 12(6)DOI:10.1002/ccr3.8803. PMID:38883222. IF:(Q/D).

del Pozo, V, Bobolea, I, Rial, MJ, Espigol-Frigolé, G, Laqué, RS, Hernández-Rivas, JM, Mora, E, Crespo-Lessmann, A, Alonso, JLI, Sosa, MSD, Maza-Solano, J, Atienza-Mateo, B, Bañas-Conejero, D, Moure, AL, Rúa-Figueroa, I. Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Frontiers in Immunology. 2024; 14DOI:10.3389/fimmu.2023.1310211. PMID:38250075. IF:5.900(Q1/2D).

Quesada-López, T, Cereijo, R, Blasco-Roset, A, Mestres-Arenas, A, Prieto, P, Domingo, JC, Villarroya, F, Domingo, P, Giralt, M. Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function. BIOCHEMICAL PHARMACOLOGY. 2024; 220DOI:10.1016/j.bcp.2023.116010. PMID:38154544. IF:5.600(Q1/1D).

Provencio, M, de Lope, LR, Serna-Blasco, R, Nadal, E, Tain, PD, Massuti, B, González-Larriba, JL, Insa, A, Sánchez-Hernández, A, Casal-Rubio, J, Garcia-Campelo, R, López, SS, Rogado, J, Martínez-Martí, A, Bosch-Barrera, J, Bernabé, R, Estévez, SV, Ponce, S, de Castro, J, Sarto, JC, Reguart, N, Dómine, M, Aguilar, A, Majem, M, Estival, A, Cabia, SP, Martín, AL, González, MAS, Cobo, M, Camps, C, Barneto, I, Calvo, V, Collazo-Lorduy, A, Cruz-Bermúdez, A, Romero, A. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC. LUNG CANCER. 2024; 194DOI:10.1016/j.lungcan.2024.107865. PMID:38945004. IF:4.400(Q1/2D).

Giménez, S, Vaqué-Alcázar, L, Zhu, NL, Benejam, B, Arranz, J, Maure-Blesa, L, Videla, L, Carmona-Iragui, M, Barroeta, I, Rebillat, AS, Rodriguez-Baz, I, Bejanin, A, Arriola-Infante, JE, Bueno, A, Fernandez, S, Ribas, L, Zsadanyi, SE, Morcillo-Nieto, AO, Alcolea, D, Lisgaras, CP, Blessing, E, Osorio, RS, Lleo, A, Fortea, J. Impact of Alzheimer's disease on sleep in adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70400. PMID:40604343. IF:11.100(Q1/1D).

Buchmeier, EL, Reck, M, Girard, N, Nadal, E, Gay, CM, Filippi, AR, Martin, LW, Petersen, C, Cairns, DA, Roch, B, Attili, I, Alvarez, RA, Boyer, A, Tarruella, MM, Robinson, A, Levra, MG, Li, L, Perez, ID, Georgoulia, N, Spicer, J. Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).

Giani, C, Baldi, GG, Ljevar, S, Denu, RA, Andelkovic, V, Han, I, Brunello, A, Napolitano, A, Bhadri, VA, Scanferla, R, Garcia, AS, Abreu, MH, Campos, F, Ogura, K, Wong, DD, Bae, S, Marquina, G, Mazzocca, A, Yang, V, Nakazawa, MS, Kim, HS, Chiusole, B, Thway, K, Antonescu, C, Bellan, E, Bovée, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Chen, TWW, Miceli, R, Gronchi, A, Stacchiotti, S. International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease. ESMO Open. 2026; 11(2)DOI:10.1016/j.esmoop.2025.106044. PMID:41564817. IF:8.300(Q1/2D).

Christoph, D, Paz-Ares, L, Borghaei, H, Liu, S, Peters, S, Herbst, R, Stencel, K, Tarruella, MM, Czyzewicz, G, Caro, RB, Lee, KH, Johnson, ML, Karadurmus, N, Grohé, C, Cuchelkar, V, Graupner, V, Kaul, M, Lin, YC, Chakrabarti, D, Bhatt, K, Reck, M. IMforte: Results from a Phase 3 study of first-line (1L) maintenance treatment (tx) with lurbinectedin (lurbi) plus atezolizumab (atezo) vs atezo in patients (pts) with ES-SCLC. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).

López-Tarruella, S, Guerrero-Zotano, A, Antolín, S, Cruz, J, Martínez, P, Rodríguez, CA, Falo, C, Rodríguez-Lescure, A, Adrover, E, Hernández, M, Andrés, R, Chacón, JI, Romero, JLA, Miguel, A, Gómez-Raposo, C, Margelí, M, González, I, Guerra, JA, Antón, A, Tibau, A, Miralles, JJ, Escudero, MJ, Bezares, S, Rojo, F, Alvarez, I. Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM). Therapeutic Advances in Medical Oncology. 2026; 18DOI:10.1177/17588359261421813. PMID:41732657. IF:4.200(Q2/3D).